Drug Trial Radar · NCT02286700
Skin Effects of a Topical Amino Acid Moisturizing Cream and Desonide in Atopic Dermatitis
Last checked: Nov 19, 2026Latest source record: Nov 11, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
42
Planned (sponsor's estimate)
Start
Nov 2014
Primary completion
Feb 2015
Study completion Mar 2015
Sponsor
- Lead sponsor
- NeoStrata Company, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Massachusetts General Hospital
- First posted
- Nov 10, 2014
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effects of an amino acid moisturizing cream and desonide cream in reducing skin symptoms associated with AD/eczema in subjects with mild to moderate atopic dermatitis/eczema.
Conditions
- Dermatitis, Atopic
- Eczema
Interventions
Desonide CreamDrug
Study cream randomized and distributed to subjects, applied twice daily for 3 weeks and evaluated ability to reduce atopic dermatitis symptoms.
Amino Acid Moisturizing CreamOther
Study cream randomized and distributed to subjects, applied twice daily for 3 weeks and evaluated ability to reduce atopic dermatitis symptoms.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in skin effects of an amino acid moisturizing cream and desonide cream in reducing skin symptoms associated with AD/eczema in subjects with mild to moderate atopic dermatitis/eczema.Time frame: 5 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Mass General Hospital: Clinical Unit for Research Trials in Skin
Boston, Massachusetts · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.